Exploring the causes and treatments of fibrosis
Official title: Fibrosis: Inflammation, Drivers, and Therapeutic Resolution
Funded at Keystone Symposia · NIH-10999346 · Data updated 2026-11-12
This conference is all about bringing together top experts to talk about fibrosis, a condition that causes too much scarring in the body, and to share ideas on how to find better treatments to help people heal and feel better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Keystone Symposia NIH-funded |
| Lab location | 1 site (Silverthorne, United States) |
| Project start | July 8, 2024 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $9,500 |
| NIH project number | 1R13AI186267-01 |
| Project ID | NIH-10999346 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals affected by fibrosis-related conditions, including those with organ damage or solid tumors.
✕Less likely to help
Patients who do not have fibrosis or related conditions may not benefit from this research.
What this research studies
This research involves a conference focused on understanding fibrosis, a condition characterized by excessive tissue scarring and poor healing. The event will bring together leading researchers to discuss the mechanisms behind fibrosis and explore potential therapeutic strategies. Participants will engage in workshops and discussions aimed at fostering collaboration and innovation in the field. The conference will also highlight the importance of identifying new targets for treatment and improving patient outcomes through advanced research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve healing and reduce the impact of fibrosis on patients.
How similar studies have gone: Previous conferences and research initiatives in fibrosis have led to significant advancements in understanding and treating this condition, indicating a promising potential for success.
Where this research is happening
-
Keystone Symposia
Silverthorne, United States Active
Researchers
- Principal investigator: Sheppard, Terry L. — Keystone Symposia
- Study coordinator: Sheppard, Terry L.
Related research
Other NIH-funded projects on the same topics.
-
Interface between immune cells and scarring in the eye
This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.
-
How often to treat schistosomiasis to protect the liver
A randomized trial will test different frequencies ofPraziquantel treatment to prevent liver damage in people aged 15–40 with schistosomiasis in Uganda.
-
Metabolic changes in cells that repair blood vessels in the eye lens to prevent scarring
A drug or approach that changes how certain cells that repair blood vessels in the eye work, to prevent scarring behind the retina in age-related macular degeneration patients treated with anti-VEGF therapy.
-
Myocardial fibrosis and fat in ART-treated women with HIV in sub-Saharan Africa
This project studies heart tissue changes in women with HIV in sub-Saharan Africa who are on antiretroviral therapy, to understand why they’re at higher risk for heart problems as they age.
-
Myocardial fibrosis and fat in ART-treated women with HIV in sub-Saharan Africa
This grant studies heart tissue changes in women living with HIV in sub-Saharan Africa to understand why heart failure risk is higher in this group.
-
Molecular clues to progressive lung scarring
Researchers are studying how lung tissue becomes progressively scarred, focusing on cell signals and receptors that may drive fibrosis in people with lung disease.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.